GSK Investigational Site

Messina, Sicily 98125

0 studies enrolling now · 3 studies all time

What they study most

Epilepsy, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• Pediatric Epilepsy Study in Subjects 1-24 Months — Completed
• Pediatric Epilepsy Trial in Subjects 1-24 Months — Completed